Annual Operating Expenses
$268.83 M
+$81.99 M+43.89%
December 31, 2021
Summary
- As of February 9, 2025, TPTX annual total operating expenses is $268.83 million, with the most recent change of +$81.99 million (+43.89%) on December 31, 2021.
- During the last 3 years, TPTX annual operating expenses has risen by +$243.19 million (+948.48%).
Performance
TPTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$124.48 M
+$49.12 M+65.18%
June 30, 2022
Summary
- As of February 9, 2025, TPTX quarterly total operating expenses is $124.48 million, with the most recent change of +$49.12 million (+65.18%) on June 30, 2022.
- Over the past year, TPTX quarterly operating expenses has stayed the same.
Performance
TPTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TPTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.9% | 0.0% |
| 3 y3 years | +948.5% | 0.0% |
| 5 y5 years | +1507.0% | 0.0% |
TPTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -39.5% |
| 5 y | 5-year | at high | -71.1% | at high | -81.5% |
| alltime | all time | at high | -93.8% | at high | -96.1% |
Turning Point Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $124.48 M(+65.2%) |
| Mar 2022 | - | $75.36 M(-4.2%) |
| Dec 2021 | $268.83 M(+43.9%) | $78.64 M(+17.2%) |
| Sep 2021 | - | $67.11 M(+8.6%) |
| Jun 2021 | - | $61.82 M(+0.9%) |
| Mar 2021 | - | $61.25 M(+27.8%) |
| Dec 2020 | $186.84 M | $47.94 M(+10.1%) |
| Sep 2020 | - | $43.54 M(+33.0%) |
| Jun 2020 | - | $32.73 M(-47.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $62.63 M(+171.5%) |
| Dec 2019 | $77.72 M(+203.1%) | $23.07 M(+4.2%) |
| Sep 2019 | - | $22.14 M(+20.0%) |
| Jun 2019 | - | $18.45 M(+31.2%) |
| Mar 2019 | - | $14.06 M(+48.4%) |
| Dec 2018 | $25.64 M(+53.3%) | $9.48 M(+54.7%) |
| Sep 2018 | - | $6.13 M(+18.5%) |
| Jun 2018 | - | $5.17 M(+6.4%) |
| Mar 2018 | - | $4.86 M |
| Dec 2017 | $16.73 M | - |
FAQ
- What is Turning Point Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual operating expenses year-on-year change?
- What is Turning Point Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly operating expenses year-on-year change?
What is Turning Point Therapeutics annual total operating expenses?
The current annual operating expenses of TPTX is $268.83 M
What is the all time high annual operating expenses for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual total operating expenses is $268.83 M
What is Turning Point Therapeutics annual operating expenses year-on-year change?
Over the past year, TPTX annual total operating expenses has changed by +$81.99 M (+43.89%)
What is Turning Point Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of TPTX is $124.48 M
What is the all time high quarterly operating expenses for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly total operating expenses is $124.48 M
What is Turning Point Therapeutics quarterly operating expenses year-on-year change?
Over the past year, TPTX quarterly total operating expenses has changed by $0.00 (0.00%)